{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:24:44Z","timestamp":1792661084249,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.ophtha.2013.12.032","type":"journal-article","created":{"date-parts":[[2014,2,8]],"date-time":"2014-02-08T15:30:24Z","timestamp":1391873424000},"page":"1246-1251","source":"Crossref","is-referenced-by-count":54,"title":["The Impact of Anti\u2013Vascular Endothelial Growth Factor Treatment on Quality of Life in Neovascular Age-Related Macular Degeneration"],"prefix":"10.1016","volume":"121","author":[{"given":"Robert P.","family":"Finger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn H.","family":"Guymer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C.","family":"Gillies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill E.","family":"Keeffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2013.12.032_bib1","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0140-6736(12)60282-7","article-title":"Age-related macular degeneration","volume":"379","author":"Lim","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ophtha.2013.12.032_bib2","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/bjo.2009.170670","article-title":"Ranibizumab for exudative age-related macular degeneration: 24-month outcomes from a single-centre institutional setting","volume":"94","author":"Querques","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2013.12.032_bib3","first-page":"405724","article-title":"One-year outcomes using ranibizumab for neovascular age-related macular degeneration: results of a prospective and retrospective observational multicentre study","volume":"2011","author":"Hjelmqvist","year":"2011","journal-title":"J\u00a0Ophthalmol"},{"key":"10.1016\/j.ophtha.2013.12.032_bib4","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00417-010-1524-5","article-title":"Long-term visual course after anti-VEGF therapy for exudative AMD in clinical practice evaluation of the German reinjection scheme","volume":"249","author":"Heimes","year":"2011","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2013.12.032_bib5","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1167\/iovs.10-7127","article-title":"The impact of vision impairment on vision-specific quality of life in Germany","volume":"52","author":"Finger","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2013.12.032_bib6","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/archopht.125.11.1460","article-title":"Improved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trial","volume":"125","author":"Chang","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2013.12.032_bib7","doi-asserted-by":"crossref","first-page":"747 e4","DOI":"10.1016\/j.ophtha.2009.09.002","article-title":"Vision-related function after ranibizumab treatment by better- or worse-seeing eye: clinical trial results from MARINA and ANCHOR","volume":"117","author":"Bressler","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2013.12.032_bib8","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1755-3768.2012.02493.x","article-title":"Treatment patterns, visual acuity and quality-of-life outcomes of the WAVE study - a noninterventional study of ranibizumab treatment for neovascular age-related macular degeneration in Germany","volume":"91","author":"Finger","year":"2013","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ophtha.2013.12.032_bib9","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1136\/bjophthalmol-2011-301201","article-title":"Patients\u2019 preferences in treatment for neovascular age-related macular degeneration in clinical routine","volume":"96","author":"Finger","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2013.12.032_bib10","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1167\/iovs.09-4494","article-title":"The psychometric validity of the NEI VFQ-25 for use in a low-vision population","volume":"51","author":"Marella","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2013.12.032_bib11","first-page":"927","article-title":"Assessment of the impact of vision impairment","volume":"43","author":"Weih","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2013.12.032_bib12","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1167\/iovs.06-0361","article-title":"The impact of vision impairment questionnaire: an assessment of its domain structure using confirmatory factor analysis and Rasch analysis","volume":"48","author":"Lamoureux","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2013.12.032_bib13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ajo.2003.08.003","article-title":"The determinants of participation in activities of daily living in people with impaired vision","volume":"137","author":"Lamoureux","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2013.12.032_bib14","doi-asserted-by":"crossref","first-page":"4732","DOI":"10.1167\/iovs.06-0220","article-title":"The Impact of Vision Impairment Questionnaire: an evaluation of its measurement properties using Rasch analysis","volume":"47","author":"Lamoureux","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2013.12.032_bib15","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.visres.2005.07.007","article-title":"The Refractive Status and Vision Profile: Evaluation of psychometric properties and comparison of Rasch and summated Likert-scaling","volume":"46","author":"Garamendi","year":"2006","journal-title":"Vision Res"},{"issue":"1 Suppl","key":"10.1016\/j.ophtha.2013.12.032_bib16","doi-asserted-by":"crossref","first-page":"I25","DOI":"10.1097\/01.mlr.0000103530.13056.88","article-title":"Comparing alternative Rasch-based methods vs raw scores in measuring change in health","volume":"42","author":"Norquist","year":"2004","journal-title":"Med Care"},{"key":"10.1016\/j.ophtha.2013.12.032_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2415-6-25","article-title":"Patient-centered measurement in ophthalmology - a paradigm shift","volume":"6","author":"Pesudovs","year":"2006","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.ophtha.2013.12.032_bib18","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.jcrs.2004.01.033","article-title":"Autorefraction as an outcome measure of laser in situ keratomileusis","volume":"30","author":"Pesudovs","year":"2004","journal-title":"J\u00a0Cataract Refract Surg"},{"key":"10.1016\/j.ophtha.2013.12.032_bib19","doi-asserted-by":"crossref","first-page":"195 e2","DOI":"10.1016\/j.ajo.2010.09.020","article-title":"Vision-specific quality-of-life research: a need to improve the quality","volume":"151","author":"Lamoureux","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2013.12.032_bib20","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/j.ophtha.2012.05.031","article-title":"Rasch analysis reveals problems with multiplicative scoring in the macular disease quality of life questionnaire","volume":"119","author":"Finger","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2013.12.032_bib21","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/OPX.0b013e318141fe75","article-title":"The development, assessment, and selection of questionnaires","volume":"84","author":"Pesudovs","year":"2007","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.ophtha.2013.12.032_bib22","first-page":"905","article-title":"Rack and stack: time 1 vs. time 2 or pre-test vs. post-test","volume":"17","author":"Wright","year":"2003","journal-title":"Rasch Measurement Transactions"},{"key":"10.1016\/j.ophtha.2013.12.032_bib23","first-page":"1171","article-title":"Repeated measure designs (time series) and Rasch","volume":"22","author":"Chien","year":"2008","journal-title":"Rasch Measurement Transactions"},{"key":"10.1016\/j.ophtha.2013.12.032_bib24","first-page":"120","article-title":"On the statistical reliability of letter-chart visual acuity measurements","volume":"34","author":"Arditi","year":"1993","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2013.12.032_bib25","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1097\/01.opx.0000187863.12609.7b","article-title":"Reliability and consistency of visual acuity and contrast sensitivity measures in advanced eye disease","volume":"82","author":"Kiser","year":"2005","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.ophtha.2013.12.032_bib26","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ajo.2008.12.005","article-title":"Effects of ranibizumab in patients with subfoveal choroidal neovascularization attributable to age-related macular degeneration","volume":"147","author":"Rothenbuehler","year":"2009","journal-title":"Am J Ophthalmol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642013012505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642013012505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T03:38:27Z","timestamp":1648265907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642013012505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0161642013012505"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2013.12.032","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}